Survival curves revealed that higher levels of EDA2R transcription were linked to poorer overall survival in breast cancer, stomach adenocarcinoma, head and neck squamous cell carcinoma, and cervical squamous cell carcinoma (Fig. 9A–D). Here, EDA2R is linked to gastric adenocarcinoma.